SFShinya Furukawa

Shinya Furukawa

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Shinya Furukawa has a total of 302 co-authors. Here are the top co-authors by number of shared publications:

  • Teruki Miyake

    Department of Lifestyle-related Medicine and Endocrinology, Ehime University Graduate School of Medicine, Toon, Japan

    42 shared publications
  • Yoichi Hiasa

    Department of Gastroenterology and Metabology, Ehime University Graduate School of Medicine, Toon, Japan

    41 shared publications
  • Eiji Takeshita

    Department of Inflammatory Bowel Diseases and Therapeutics, Ehime University Graduate School of Medicine, Ehime 791-0295, Japan

    33 shared publications
  • Yoshio Ikeda

    Endoscopy Center, Ehime University Hospital, Toon, Ehime 791-0295, Japan

    33 shared publications
  • Yasunori Yamamoto

    Endoscopy Center, Ehime University Hospital, Toon, Ehime 791-0295, Japan

    32 shared publications
  • Yoichi Hiasa

    Department of Gastroenterology and Metabology, Ehime University Graduate School of Medicine, Toon City 791-0295, Japan

    27 shared publications

Latest Publications

  • Open Access

    Associations of exercise characteristics and exercise partners with self-reported atopic dermatitis among Japanese university students

    by Junichi Watanabe, Hironobu Nakaguchi, Shinya Furukawa, Teruki Miyake, Masumi Miyazaki, Ayumi Kanamoto, Yoshimasa Murakami, Keiichiro Horiuchi, Osamu Yoshida, Aki Kato, et al.

    Background: Atopic dermatitis (AD) is a prevalent chronic inflammatory skin disease; however, its association with physical activity remains inconclusive. The role of the social context of exercise, including exercise partners, is also unclear. This study examined associations between exercise characteristics and self-reported AD among Japanese young adults. Methods: This cross-sectional study included 12,494 university students in Japan. Exercise frequency, perceived intensity, and exercise partner were assessed using a self-administered questionnaire. Self-reported AD was ascertained by asking participants whether they had previously been diagnosed with AD. Odds ratios (ORs) and 95% confidence intervals (CIs) were estimated using logistic regression. Each exercise characteristic was first examined individually, adjusting for age, sex, body mass index, drinking, smoking, systolic blood pressure, and self-reported sleep duration. Exercise frequency, intensity, and partner were then entered simultaneously into a mutually adjusted model to assess whether these associations were independent of one another. Results: The prevalence of self-reported AD was 6.5%. In the individually adjusted models, high exercise frequency (≥ 4 times/week), intense exercise, and group exercise were associated with lower odds of AD compared with no exercise, exercising alone, or light exercise, respectively (adjusted ORs: 0.72 [95% CI: 0.56–0.92], 0.75 [0.61–0.91], and 0.71 [0.56–0.88]); exercising alone or with friends was not significantly associated with AD. When exercise frequency, intensity, and partner were mutually adjusted for one another, the overall associations of exercise frequency and intensity with AD were no longer statistically significant. For exercise partner, group exercise remained associated with lower odds of AD than exercising alone (OR: 0.77 [95% CI: 0.59–0.98]), although the overall association across categories of exercise partner did not reach statistical significance. Conclusions: Higher exercise frequency, greater exercise intensity, and group exercise were each inversely associated with self-reported AD when examined individually. However, after mutual adjustment for other exercise characteristics, these associations were generally attenuated, and only a modest inverse association for group exercise remained. These findings should therefore be interpreted with caution, and causal inference is further limited by the cross-sectional design.

  • Open Access

    Underweight at age 20 and pre‐pregnancy and large‐for‐gestational‐age births in Japanese women with gestational diabetes mellitus: Hamamatsu GRACE Study 4

    by Shinya Furukawa, Ayumi Kanamoto, Yukino Toyama, Kei Takeshita, Takuya Hashimoto, Teruki Miyake, Daisuke Tsuriya

    Aims/Introduction: While maternal obesity is a well‐established risk factor for large‐for‐gestational‐age (LGA) infants, the impact of maternal underweight on LGA in women with gestational diabetes mellitus (GDM) remains inconsistent. This issue is particularly relevant in Japan, given the high prevalence of underweight women. We investigated the association between maternal weight and body mass index (BMI) at age 20 and pre‐pregnancy and the risk of LGA in Japanese women with GDM. Materials and Methods: This retrospective study analyzed 537 Japanese women with GDM. Participants were categorized by BMI (underweight 2 , normal, and obesity ≥25.0 kg/m 2 ) and by weight quartiles at age 20 and pre‐pregnancy. Multivariable logistic regression analyses were performed to calculate adjusted odds ratios (ORs) and 95% confidence intervals (CIs) for the association between underweight at age 20 and pre‐pregnancy and LGA. Results: The prevalence of underweight at age 20, underweight pre‐pregnancy, and LGA was 30.4%, 13.4%, and 9.7%, respectively. After adjustment for confounders, underweight based on BMI at age 20 (adjusted OR 0.22, 95% CI: 0.06–0.75) and pre‐pregnancy (adjusted OR 0.17, 95% CI: 0.03–0.64) was significantly and inversely associated with LGA compared with obesity. Similarly, the lowest weight quartiles at both time points were independently associated with a low risk of LGA. Conclusions: Maternal underweight at age 20 and pre‐pregnancy was significantly associated with a lower risk of LGA in Japanese women with GDM. These findings suggest that weight status from early adulthood may play a crucial role in fetal growth outcomes.

  • Fecal incontinence among patients with ulcerative colitis and relation with disease activity, and extent: A cross-sectional study

    by Masakazu Hanayama, Shinya Furukawa, Teruki Miyake, Osamu Yoshida, Kana Shiraishi, Kazuhiro Tange, Yu Hashimoto, Seiyuu Suzuki, Katsuhisa Ohashi, Hideomi Tomida, et al.

  • Open Access

    Association Between Toothbrushing Habits and Mucosal Healing in Japanese Patients with Ulcerative Colitis

    by Sen Yagi, Shinya Furukawa, Teruki Miyake, Osamu Yoshida, Kazuhiro Tange, Shogo Kitahata, Tomoyuki Ninomiya, Masakazu Hanayama, Seiyuu Suzuki, Naozumi Shibata, et al.

    Evidence regarding the association between oral environment and the inflammatory bowel disease (IBD), including ulcerative colitis (UC), exists. However, evidence regarding the association between oral health parameters and disease activity of UC is limited. This study aimed to evaluate the association between remaining tooth number and toothbrushing frequency and mucosal healing (MH) in Japanese UC patients. The study included 275 patients with UC. Information on lifestyle and oral health parameters was collected via self-administered questionnaires. The definition of MH was based on the Mayo endoscopic subscore (MES) of 0. The prevalence of MH in this cohort was 24.7%. The distribution of remaining teeth was as follows: 13.1% had 20 or fewer teeth, 32.7% had 20-27 teeth, and 54.2% had 28 teeth. Toothbrushing frequency was 23.6% brushed once or less per day, 46.9% brushed twice per day, and 29.5% brushed three or more times per day. No significant difference was observed between remaining teeth and MH. However, toothbrushing frequency is independently positively associated with MH (adjusted odds ratio: 2.87 [95% CI: 1.19-7.29]; p value for trend = 0.021). Toothbrushing frequency but not the remaining tooth number might be independently and positively associated with MH in Japanese patients with UC.

  • Body mass index and mucosal healing in Japanese patients with ulcerative colitis: A cross-sectional study

    by Masakazu Hanayama, Shinya Furukawa, Teruki Miyake, Osamu Yoshida, Hironubu Nakaguchi, Ayumi Kanamoto, Masumi Miyazaki, Yoshimasa Murakami, Keiichiro Horiuchi, Kazuhiro Tange, et al.

    Purpose: Ulcerative colitis (UC) is a chronic inflammatory bowel disease, and obesity is thought to exacerbate disease activity via chronic low-grade inflammation and related metabolic and cytokine dysregulation. However, evidence on the relationship between obesity and UC remains limited and inconsistent. As mucosal healing (MH) is an established therapeutic goal in UC, we aimed to investigate the association between body mass index (BMI) and MH in Japanese patients with UC. Methods: This study included 292 Japanese UC patients. One endoscopist evaluated complete mucosal healing (CMH), defined as Mayo endoscopic sub-scores of 0. Underweight and obesity were defined as BMI <18.5 and ≥25 kg/m2, respectively. For detailed analysis, BMI was divided into quartiles: low: <19.70 kg/m2, lower-middle: 19.70–21.82 kg/m2, upper-middle: 21.83–24.60 kg/m2, and high: ≥24.61 kg/m2. Multivariable logistic regression models were used to adjust for potential confounders and to evaluate the associations of BMI categories with MH. Results: The mean age, male ratio, CMH rate, and clinical remission rate were 50.3 years, 57.9%, 25.0%, and 59.6%, respectively. No clear association between underweight, normal weight, or obesity and CMH was observed; however, in the quartile analysis, the highest BMI was independently and positively associated with CMH in the younger group, but not in the older group (adjusted OR: 0.29, 95% CI: 0.07–0.97). Conclusion: BMI was independently and inversely associated with CMH in Japanese younger patients with UC, but this association was not observed in older patients.

  • Fibrosis‐4 Index as a Robust Long‐Term Predictor of Cancers in Metabolic Dysfunction–Associated Steatotic Liver Disease

    by Ayumi Kanamoto, Teruki Miyake, Shinya Furukawa, Osamu Yoshida, Keiichiro Horiuchi, Yoshimasa Murakami, Masumi Miyazaki, Hironobu Nakaguchi, Ryo Yano, Yuki Okazaki, et al.

    Aim: We investigated whether the baseline fibrosis‐4 (FIB‐4) index stratifies long‐term cancer risk in patients with biopsy‐proven MASLD and compared its discrimination for HCC and extrahepatic malignancies against other noninvasive fibrosis markers. Methods: In this single‐center retrospective cohort study, 417 adults with biopsy‐proven MASLD (2001–2024) were followed for incident malignancy (median follow‐up, 4.75 years). Patients were categorized using standard FIB‐4 thresholds (< 1.3, 1.3–2.67, ≥ 2.67). Cause‐specific Cox models and Fine–Gray competing‐risk models were used to estimate adjusted hazard ratios (HRs) for HCC and extrahepatic cancer. Discriminative performance was evaluated using Harrell's C‐index and time‐dependent area under the curve (AUC) values at 3, 5, and 10 years. Results: During followup, 24 patients (5.8%) developed HCC, whereas 40 (9.6%) developed extrahepatic cancer. The ≥ 2.67 category was associated with markedly increased risks of HCC (adjusted HR 35.31) and extrahepatic cancer (adjusted HR 13.10) compared with < 1.3. Associations remained robust in competing‐risk and age‐adjusted sensitivity analyses. FIB‐4 showed the highest and most consistent discriminative performance among the evaluated indices (C‐indices of 0.83 for HCC and 0.78 for extrahepatic cancer). Time‐dependent AUCs improved over time and exceeded 0.80 for HCC after 5 years. Conclusion: The FIB‐4 index provides consistent long‐term risk stratification for HCC and shows an association with extrahepatic cancer among commonly used noninvasive fibrosis markers. Its strong time‐dependent discrimination for HCC and moderate discrimination for extrahepatic cancer support its potential role as a simple, widely accessible tool for long‐term risk stratification in MASLD.


  • Open Access

    Renal function trajectories before and during the COVID-19 pandemic in Japanese individuals with type 1 diabetes: a post-hoc analysis of the multicenter retrospective investigation by the IPRA-CKD study group

    by Yuta Nakamura, Hiroshi Yano, Norio Abiru, Hiroshi Nomoto, Tomoyasu Fukui, Yoshihiko Yuyama, Tomoyuki Kawamura, Mariko Ueda, Akane Yamamoto, Yushi Hirota, et al.

    The coronavirus disease 2019 (COVID-19) pandemic and associated lifestyle changes have affected metabolic status in individuals with diabetes. The impact of these changes on renal function in individuals with type 1 diabetes (T1D) remains unclear. We performed a post-hoc analysis of a multicenter retrospective cohort study (the IPRA-CKD study) including 190 Japanese individuals with T1D who were not receiving sodium–glucose cotransporter 2 inhibitors. Participants were recruited between June 2022 and July 2023, and longitudinal data over a consecutive 60-month period preceding enrollment were extracted at 6-month intervals and divided into periods before and during the pandemic. Annual rates of estimated glomerular filtration rate (eGFR) decline were compared between the periods before and during the COVID-19 pandemic using a linear mixed-effects model. The eGFR decline was not accelerated during the pandemic compared with before the pandemic; the estimated eGFR slopes were –1.54 ± 0.28 mL/min/1.73 m2/year before the pandemic and –1.05 ± 0.22 mL/min/1.73 m2/year during the pandemic (p = 0.27). Glycemic control was preserved during the pandemic, despite small but significant increases in body weight, blood pressure, and insulin dose. Exploratory subgroup analyses suggested a less steep eGFR decline during the pandemic among participants with body mass index ≥25 kg/m2 or those receiving renin–angiotensin system inhibitors; however, these findings should be interpreted as hypothesis-generating. In this multicenter cohort of individuals with T1D, the COVID-19 pandemic was not associated with accelerated eGFR decline overall.Clinical Trial Registry (CTR) registration: UMIN-CTR000047441

  • Open Access

    Association between fasting plasma glucose at diagnosis and large-for-gestational-age in Japanese women with gestational diabetes mellitus: Hamamatsu GRACE Study 6

    by Daisuke Tsuriya, Kei Takeshita, Yukino Toyama, Takuya Hashimoto, Ayumi Kanamoto, Teruki Miyake, Shinya Furukawa

    Maternal high fasting plasma glucose (FPG) is a well-known risk factor for large-for-gestational-age (LGA) infants. However, this association remains unclear among Japanese women with gestational diabetes mellitus (GDM). Therefore, we examined this issue in Japanese women with GDM, accounting for body mass index (BMI). This retrospective study analyzed 543 Japanese women with GDM and evaluated the associations of 1-standard deviation (SD) increments in fasting, 1-hour, and 2-hour plasma glucose and HbA1c levels with LGA. LGA was defined as birth weight above the 90th percentile for gestational age. Multivariable logistic regression was used to estimate ORs and 95% CIs for LGA per 1-SD increment in fasting, 1-hour, and 2-hour plasma glucose and HbA1c. Model 1 was adjusted for maternal age, smoking, family history of diabetes, insulin use, parity, gestational age at delivery, gestational age at diagnosis, and gestational weight gain; Model 2 was additionally adjusted for pre-pregnancy BMI. The prevalence of LGA was 9.6%. In model 1, the FPG was independently and positively associated with LGA (adjusted OR 1.44, 95% CI: 1.07–1.94). The area under the receiver operating characteristic (ROC) curve for FPG in discriminating LGA was 0.692, with an optimal cutoff of 86.0 mg/dL. After additional adjustment for pre-pregnancy BMI (model 2), FPG was no longer associated with LGA. Other glycemic parameters were not associated with low birth weight, small-for-gestational-age, or LGA. FPG at GDM diagnosis may provide limited discriminatory information for LGA. However, its association with LGA was attenuated after adjustment for pre-pregnancy BMI.

  • Open Access

    Pre-pregnancy body mass index and neonatal body weight in Japanese women with gestational diabetes mellitus: Hamamatsu GRACE Study 1

    by Kei Takeshita, Takuya Hashimoto, Yukino Toyama, Ayumi Kanamoto, Teruki Miyake, Shinya Furukawa, Daisuke Tsuriya

    Gestational diabetes mellitus (GDM) is closely associated with adverse fetal outcomes. Maternal underweight is associated with low birth weight (LBW) and small for gestational age (SGA). Despite the high proportion of underweight women with GDM in Asian populations, evidence on the association between underweight and the risk of LBW or SGA in GDM is limited and inconsistent. The aim of this study is to investigate this issue in Japanese women with GDM. We enrolled 641 women with GDM at the Hamamatsu University Hospital. Data on maternal body mass index (BMI), and fetal birth weight (including LBW and SGA) were collected from medical records. Logistic regression analysis was used to estimate crude odds ratios (ORs) and 95% confidence intervals (CIs) for the association between underweight and fetal birth weight. At pre-pregnancy, the prevalences of underweight (BMI <18.5 kg/m2), obesity (BMI ≥25 kg/m2), SGA, and LBW were 13.5%, 26.4%, 7.2%, and 13.3%, respectively. Pre-pregnancy underweight was independently and positively associated with SGA (adjusted OR: 2.56, 95% CI: 1.15–5.46) and LBW (adjusted OR: 3.07, 95% CI: 1.31–7.13). Obesity at age 20 but not at pre-pregnancy was independently and inversely associated with SGA (adjusted OR: 0.11, 95% CI: 0.01–0.88). In conclusion, among Japanese women with GDM, pre-pregnancy underweight, but not underweight at age 20, was significantly associated with SGA and LBW. On the other hand, obesity at age 20 was independently and inversely associated with SGA.


  • Open Access

    Effect of body mass index change on the development of diabetes mellitus

    by Masahiro Okano, Teruki Miyake, Shinya Furukawa, Osamu Yoshida, Yoshimasa Murakami, Ayumi Kanamoto, Masumi Miyazaki, Akihito Shiomi, Hironobu Nakaguchi, Yasunori Yamamoto, et al.

    A high body mass index (BMI) is associated with the onset of diabetes mellitus (DM). However, evidence regarding the association between changes in BMI and DM onset is limited, and the effect of annual BMI (kg/m2/year) change on DM onset is unknown. Therefore, we assessed the effects of changes in BMI and annual BMI on DM onset. We enrolled 13,949 participants aged 21–81 years who underwent an annual health checkup at least twice between April 2003 and March 2021 and examined the effect of BMI change and annual BMI change on DM onset. In total, 462 individuals newly developed DM. Compared with a BMI change of –0.25–<0.25, univariate and multivariate analyses—adjusted for age, sex, BMI, systolic blood pressure, creatinine, total cholesterol, triglycerides, alanine aminotransferase, hemoglobin A1c, and family history of DM—showed that a BMI change <–2 was associated with a lower risk, while 2 ≤ BMI change < 4 and 4 ≤ BMI change were associated with a higher risk of DM onset. In contrast, compared with –0.05 ≤ BMI change per year < 0.05, univariate and multivariate analyses showed a significant association between DM onset and 0.3 ≤ BMI change per year. In the age-stratified analysis, these associations were significant among younger and middle-aged participants but not in older adults. In conclusion, changes in BMI affect DM onset. Therefore, clinicians can prevent DM onset by providing guidance based on BMI and focusing on a ≥2 increase in BMI and a ≥0.3 increase per year of BMI in young and middle-aged individuals.